Chromosomal damage and micronucleus induction by MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor: Evidence for a non-DNA-reactive mode of action.

Abstract

MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor that competes with the binding of the PARP substrate nicotinamide adenine dinucleotide (NAD), is being developed as a neuroprotective agent against acute ischemic stroke. MP-124 increased structural chromosomal aberration in CHL/IU cells, but showed negative results in the bacterial reverse mutation test, and the rat bone marrow micronucleus (MN) and the rat liver unscheduled DNA synthesis tests after the intravenous bolus injection. Thus, MP-124 did not appear to be direct-acting mutagen. Since, PARP-1 is a key enzyme in DNA repair, the effect of continuous PARP-1 inhibition by MP-124 was further examined in the rat MN test under 24-h intravenous infusion, and an increase in micronucleated immature erythrocytes (MNIE) was observed. The increase was clearly reduced by co-treatment with nicotinic acid, which resulted in increased intracellular NAD levels. This is consistent with the established activity of MP-124 as a competitive inhibitor of PARP and provides strong evidence that the DNA-damaging effect that leads to the increase in MNIE is a secondary effect of PARP-1 inhibition. This mechanism is expected to result in a threshold for the induction of MNIE by MP-124, and allows for the establishment of a safe margin of exposure for the therapeutic use of MP-124.

• Authors: Eiji Yamamura, Shigeharu Muto, Katsuya Yamada, Yuko Sato, Yumiko Iwase, Yoshifumi Uno
• Journal: Mutation research. Genetic toxicology and environmental mutagenesis (Mutat Res Genet Toxicol Environ Mutagen) Vol. 782 Pg. 1-8 (Apr 2015) ISSN: 1879-3592 [Electronic] Netherlands
• PMID: 25868125 (Publication Type: Journal Article)
• Copyright: Copyright © 2015 Elsevier B.V. All rights reserved.

Chemical References

• Isoquinolines
• MP 124
• Poly(ADP-ribose) Polymerase Inhibitors
• Vitamin B Complex
• Niacin
• Poly(ADP-ribose) Polymerases

Topics

• Animals
• Chromosome Aberrations (chemically induced)
• DNA Damage
• Dose-Response Relationship, Drug
• Erythrocytes (drug effects, metabolism)
• Infusions, Intravenous
• Isoquinolines (administration & dosage, toxicity)
• Male
• Micronuclei, Chromosome-Defective (chemically induced, drug effects)
• Micronucleus Tests
• Mutagenicity Tests (methods)
• Niacin (administration & dosage, pharmacology)
• Poly(ADP-ribose) Polymerase Inhibitors
• Poly(ADP-ribose) Polymerases (metabolism)
• Rats, Sprague-Dawley
• Vitamin B Complex (pharmacology)